Health expenditure growth: Looking beyond the average through decomposition of the full distribution
| Autor: | Claudine de Meijer, Owen O'Donnell, Eddy van Doorslaer, Marc A. Koopmanschap |
|---|---|
| Přispěvatelé: | Health Economics (HE), Applied Economics |
| Rok vydání: | 2013 |
| Předmět: |
Adult
Male Hospital practice Critical Care Biomedical Technology Distribution (economics) Health care expenditure decomposition aging pharmaceuticals the Netherlands Drug Costs Decomposition (computer science) Economics Hospital discharge Humans Economics Hospital skin and connective tissue diseases Netherlands Public economics Delivery of Health Care Integrated Technological change business.industry Health Policy Public Health Environmental and Occupational Health jel:I10 Hospital care Models Economic Female Demographic economics sense organs Health Expenditures business Delivery of Health Care |
| Zdroj: | Journal of Health Economics, 32(1), 88-105. Elsevier |
| ISSN: | 0167-6296 |
| DOI: | 10.1016/j.jhealeco.2012.10.009 |
| Popis: | This discussion paper resulted in an article in the Journal of Health Economics (2013). Volume 32, pages 88-105. Explanations of growth in health expenditures have restricted attention to the mean. We explain change throughout the distribution of expenditures, providing insight into how growth and its explanation differ along the distribution. We analyse Dutch data on actual health expenditures linked to hospital discharge and mortality registers. Full distribution decomposition delivers findings that would be overlooked by examination of changes in the mean alone. The growth in expenditures on hospital care is strongest at the middle of the distribution and is driven mainly by changes in the distributions of determinants. Pharmaceutical expenditures increase most at the top of the distribution and are mainly attributable to structural changes, including technological progress, making treatment of the highest cost cases even more expensive. Changes in hospital practice styles make the largest contribution of all determinants to increased spending not only on hospital care but also on pharmaceuticals, suggesting important spill over effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect